Genentech announced this morning before the bell that a Phase III trial testing their new drug Avastin with chemotherapy improved overall survival in previously untreated patients with metastatic colorectal cancer.-áThis is significant news.-áAvastin is a monoclonal antibody aimed at a
The post Why Genentech Is In Play Today appeared first on TradingMarkets.com.